Author

A. Martens

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. de Bruin· 1 shared A. Franke· 1 shared A. Haase· 1 shared A. Haverich· 1 shared A. Hilfiker· 1 shared A. M. Sponaas· 1 shared A. Moussavi· 1 shared A. Schrod· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. de Bruin

Author profile →

3 papers

Recent·Most cited

Cell therapy with human iPSC-derived cardiomyocyte aggregates leads to efficient engraftment and functional recovery after myocardial infarction in non-human primates

I. Gruh, A. Martens, S. Cebotari, A. Schrod, A. Haase, C. Halloin, W. Triebert, T. Goecke, M. Arar, K. Hoeffler, P. Frank, K. Lampe, A. Moussavi, V. Fricke, N. Kriedemann, , U. Martin

This study transplants human iPSC-derived cardiomyocyte aggregates into non-human primates with myocardial infarction, showing efficient engraftment and functional recovery with lower cell doses than previous single-cell approaches.

bioRxiv · Dec 31, 2023 · PreprintCell Biology

OTULIN prevents liver inflammation and hepatocellular carcinoma by inhibiting FADD- and RIPK1 kinase-mediated hepatocyte apoptosis

L. Verboom, A. Martens, D. Priem, E. Hoste, M. Sze, H. Vikkula, S. Voet, L. Bongiovanni, A. de Bruin, C. L. Scott, M. Pasparakis, M. J. Bertrand, G. van Loo

bioRxiv · Sep 19, 2019Cancer Biology

Bone morphogenetic protein 4 gene therapy in mice inhibits myeloma tumor growth, but has a negative impact on bone

M. Westhrin, T. Holien, M. Zahoor, S. H. Moen, G. Buene, B. Stordal, H. Hella, H. Yuan, J. D. de Bruijn, A. Martens, R. W. Groen, F. Bosch, U. Smith, A. M. Sponaas, A. Sundan, T. Standal

This study shows that BMP4 gene therapy reduces myeloma tumor growth in mice but also decreases trabecular bone volume.

bioRxiv · Mar 13, 2019Cancer Biology